These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 29611113)

  • 1. Natural and synthetic polymer-based smart biomaterials for management of ulcerative colitis: a review of recent developments and future prospects.
    Sohail M; Mudassir ; Minhas MU; Khan S; Hussain Z; de Matas M; Shah SA; Khan S; Kousar M; Ullah K
    Drug Deliv Transl Res; 2019 Apr; 9(2):595-614. PubMed ID: 29611113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel biodegradable pH-sensitive hydrogels: An efficient controlled release system to manage ulcerative colitis.
    Abbasi M; Sohail M; Minhas MU; Khan S; Hussain Z; Mahmood A; Shah SA; Kousar M
    Int J Biol Macromol; 2019 Sep; 136():83-96. PubMed ID: 31195039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis.
    Xu J; Tam M; Samaei S; Lerouge S; Barralet J; Stevenson MM; Cerruti M
    Acta Biomater; 2017 Jan; 48():247-257. PubMed ID: 27769943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.
    You YC; Dong LY; Dong K; Xu W; Yan Y; Zhang L; Wang K; Xing FJ
    Carbohydr Polym; 2015 Oct; 130():243-53. PubMed ID: 26076623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistage-Responsive Nanocomplexes Attenuate Ulcerative Colitis by Improving the Accumulation and Distribution of Oral Nucleic Acid Drugs in the Colon.
    Li X; Yang Y; Wang Z; Ju H; Fu X; Zou L; Li M; Xue Q; Ma H; Meng Y; Zhao L; Qi H; Yu T
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):2058-2070. PubMed ID: 34978415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Assembled Polymers for Gastrointestinal Tract Targeted Delivery through the Oral Route: An Update.
    Yang X; Yang Y; Yu H; Zhou Y
    Polymers (Basel); 2023 Aug; 15(17):. PubMed ID: 37688164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice.
    Bai XY; Yan Y; Wang L; Zhao LG; Wang K
    Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
    Bayram B; Ozgur A; Tutar L; Tutar Y
    Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsive nanosystems for targeted therapy of ulcerative colitis: Current practices and future perspectives.
    Chen M; Lan H; Jin K; Chen Y
    Drug Deliv; 2023 Dec; 30(1):2219427. PubMed ID: 37288799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydrogel drug delivery system for treating ulcerative colitis: A preclinical meta-analysis.
    Jiang L; Li J; Yang R; Chen S; Wu Y; Jin Y; Wang J; Weng Q; Wang J
    Int J Pharm; 2024 Jun; 659():124281. PubMed ID: 38802026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural and synthetic biomaterials for controlled drug delivery.
    Kim JK; Kim HJ; Chung JY; Lee JH; Young SB; Kim YH
    Arch Pharm Res; 2014 Jan; 37(1):60-8. PubMed ID: 24197492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable hydrogels for sustained release of therapeutic agents.
    Thambi T; Li Y; Lee DS
    J Control Release; 2017 Dec; 267():57-66. PubMed ID: 28827094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review on Magnetic Natural Polymer Constructed Hydrogels as Vehicles for Drug Delivery.
    Liao J; Huang H
    Biomacromolecules; 2020 Jul; 21(7):2574-2594. PubMed ID: 32543834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomaterials in treatment of Alzheimer's disease.
    Agrawal M; Prathyusha E; Ahmed H; Dubey SK; Kesharwani P; Singhvi G; Naidu VGM; Alexander A
    Neurochem Int; 2021 May; 145():105008. PubMed ID: 33684545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.
    Xiao B; Zhang Z; Viennois E; Kang Y; Zhang M; Han MK; Chen J; Merlin D
    Theranostics; 2016; 6(12):2250-2266. PubMed ID: 27924161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-assembling polymeric nanocarriers to target inflammatory lesions in ulcerative colitis.
    Courthion H; Mugnier T; Rousseaux C; Möller M; Gurny R; Gabriel D
    J Control Release; 2018 Apr; 275():32-39. PubMed ID: 28774843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.